Drugs / Wen Xin granule
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04661709 | Mar 2021 → Mar 2023 | intermediate coronary syndrome | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wen Xin granule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04661709 ↗ |
| Route | Oral | “Patients are given Wen Xin granule by mouth, one dose daily for 2 months” NCT04661709 ↗ |